Exchange: NASDAQ·Updated 04:15 PM EST

RCEL News

News
all
press releases
Avita Medical (NASDAQ:RCEL) Shares Up 4.6% - Still a Buy?
Avita Medical (NASDAQ:RCEL) Shares Climb 4.6% - Should You Buy...
MarketBeat
Avita Medical (NASDAQ:RCEL) Shares Up 4.6% - Still a Buy?
Avita Medical (NASDAQ:RCEL) Shares Climb 4.6% - Should You Buy...
MarketBeat
More News
AVITA Medical Shares Rose 329% In A Year, Medicare Resets Its Billing Codes Next...
SeekingAlpha
Avita Medical (RCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Avita Medical (RCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Does Avita Medical Inc. (RCEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out yesterday.read more...
Benzinga
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics (NASDAQ:LSTA)read more...
Benzinga
Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks

Advertisement|Remove ads.